NovaBridge Biosciences (NBP) Enterprise Value (2018 - 2025)
NovaBridge Biosciences (NBP) reported Enterprise Value of -$210.8 million for Q4 2025, down 21.59% year-over-year from -$268.9 million in Q4 2024, and up 7.64% quarter-over-quarter from -$228.3 million in Q3 2025.
NovaBridge Biosciences (NBP) Enterprise Value (2018 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 8 years of Enterprise Value data on file, last reported at -$210.8 million in Q4 2025.
- Enterprise Value for Q4 2025 came in at -$210.8 million, down 21.59% year-over-year; the trailing twelve-month figure through Dec 2025 was -$210.8 million (down 21.59% YoY), and the FY2025 annual result was -$210.8 million, down 21.59% from the prior year.
- Enterprise Value grew to -$210.8 million in Q4 2025 per NBP's latest filing, from -$228.3 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$165.6 million in Q2 2025 and troughed at -$118.4 billion in Q4 2021.
- A 5-year average of -$9.4 billion and a median of -$366.2 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2021 and 2022: Enterprise Value slumped 16273.69% in 2021, then surged 99.61% in 2022.
- A 5-year view of Enterprise Value shows it stood at -$118.4 billion in 2021, then jumped by 99.61% to -$465.5 million in 2022, then soared by 31.84% to -$317.3 million in 2023, then jumped by 45.35% to -$173.4 million in 2024, then dropped by 21.59% to -$210.8 million in 2025.
- Business Quant data shows NBP's Enterprise Value at -$210.8 million in Q4 2025, -$228.3 million in Q3 2025, and -$165.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -584.73 Mn |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | -210.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -210.84 Mn |
| Sep 30, 2025 | -228.27 Mn |
| Jun 30, 2025 | -165.61 Mn |
| Mar 31, 2025 | -168.62 Mn |
| Dec 31, 2024 | -173.40 Mn |
| Sep 30, 2024 | -415.73 Mn |
| Jun 30, 2024 | -366.19 Mn |
| Dec 31, 2023 | -317.31 Mn |
| Jun 30, 2023 | -420.55 Mn |
| Dec 31, 2022 | -465.51 Mn |
| Jun 30, 2022 | -594.77 Mn |
| Dec 31, 2021 | -118.35 Bn |
| Jun 30, 2021 | -737.90 Mn |
| Dec 31, 2020 | -722.83 Mn |
| Sep 30, 2020 | -388.53 Mn |
| Jun 30, 2020 | -221.08 Mn |
| Dec 31, 2019 | -169.30 Mn |
| Sep 30, 2019 | -170.21 Mn |
| Dec 31, 2018 | -243.11 Mn |